Lung Cancer
Article
COVID-19 vaccination in cancer patients: NCCN outlines priorities
Recommended timing of vaccination varies based on cancer and treatment type.
Conference Coverage
AI can identify biomarkers and potentially guide therapy in NSCLC
Deep learning models accurately predicted PD-L1 positivity and EGFR mutational status in patients with non–small cell lung cancer.
News
Lung disease raises mortality risk in older RA patients
Presence of RA-associated interstitial lung disease was associated with increased total, respiratory, and cancer mortality.
News
Lung cancer screening during pandemic: Paused, then rebounded across patient subgroups
An analysis finds similar declines and rebounds in screening among Whites and non-Whites.
News
U.S. cancer death rates drop for second year in a row
Mortality from cancer continues to decline in the United States, driven largely by major reductions in death rates from non–small cell lung cancer...
Original Research
Liquid Biopsies in a Veteran Patient Population With Advanced Prostate and Lung Non-Small Cell Carcinomas: A New Paradigm and Unique Challenge in Personalized Medicine
Minimally invasive liquid biopsy shows great promise as both a diagnostic and prognostic tool in the personalized clinical management of advanced...
News
‘Contrary’ to wide belief, abscopal effect is rare in cancer
The abscopal effect, whereby tumors are reduced or eliminated even though they are situated outside the radiation field, was first described in...
Conference Coverage
Two different radiation boost strategies reduce local failures in NSCLC
News
FDA OKs osimertinib as first adjuvant drug for NSCLC
The approval is based on results of the ADAURA trial.
Perspectives
COVID-19 vaccines and cancer patients: 4 things to know